Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listVonoprazan fumarate

Vonoprazan fumarate

  • CAS NO.:1260141-27-2
  • Empirical Formula: C21H20FN3O6S
  • Molecular Weight: 461.4634032
  • MDL number: MFCD18633280
  • EINECS: 250-635-4
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-19 23:02:33
Vonoprazan fumarate Structural

What is Vonoprazan fumarate?

Description

Vonoprazan fumarate (Takecab®), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer, duodenal ulcer and reflux esophagitis. Vonoprazan fumarate has a novel mechanism of action called potassium-competitive acid blockers, which competitively inhibit the binding of potassium ions to H+, K+-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. Vonoprazan does not inhibit Na+, K+-ATPase activity even at concentrations 500 times higher than that of their IC50 values against gastric H+, K+-ATPase activity. Furthermore, the drug is unaffected by the gastric secretory state, unlike PPIs.

Description

Vonoprazan is a selective, reversible, and potassium-competitive proton pump inhibitor that inhibits gastric H+/K+ ATPase (IC50 = 17 nM) but does not inhibit porcine Na+/K+ ATPase activity when used at a concentration of 10 μM. It maintains its inhibitory effect in both weakly acidic (pH 6.5) and neutral (pH 7.5) conditions with IC50 values of 19 and 28 nM, respectively. In vivo, vonoprazan (1, 2, and 4 mg/kg) inhibits histamine-stimulated acid secretion in a dose-dependent manner in rats, with complete inhibition when administered at a dose of 4 mg/kg. It also inhibits acid secretion for more than 48 hours in dogs when administered at doses ranging from 0.1 to 1 mg/kg.

The Uses of Vonoprazan fumarate

Vonoprazan Fumarate is a novel potassium-competitive acid blocker for the treatment of acid-related diseases.

What are the applications of Application

Vonoprazan fumarate is an oral, newly synthesised potassium-competitive acid blocker (P-CAB) with antisecretory activity. It is also a proton pump inhibitor (PPI) reversibly inhibiting H+/K+, ATPase. It is mainly used in the treatment of acid-related diseases such as GERD and peptic ulcer disease.

Synthesis

Commercially available 2-fluoroacetophenone (283) was brominated to yield a-bromo-acetophenone derivative 284. This compound was treated with ethyl 2-cyanoacetate (285) under basic conditions to provide ketoester 286 in essentially quantitative yield. Next, intramolecular condensation of 286 upon treatment of 4 M HCl furnished the tri-substituted pyrrole 287 in 53% yield. Reduction of the chloride under hydrogenolytic conditions facilitated arrival at pyrrole 288, albeit in just 18% yield. Subsequent diisobutylaluminium hydride (DIBAL) reduction, followed by the oxidation with tetrapropylammonium perruthenate (TPAP) and 4-methylmorpholine N-oxide (NMMO) afforded the corresponding aldehyde 290 in 60% yield across the 2 steps. Next, N-pyrrole substitution with pyridine- 3-sulfonyl chloride 291 gave rise to N-sulfonylpyrrole 292 in 82% yield. Reductive amination of 292 afforded amine 293, which was treated with fumaric acid (294) via co-crystallization to provide vonoprazan fumarate (XXXVI) in 74% for the two steps.

Synthesis_1260141-27-2

References

[1]. yasunobu hori, jun matsukawa, toshiyuki takeuchi, et al. a study comparing the antisecretory effect of tak-438, a novel potassium-competitive acid blocker, with lansoprazole in animals. journal of pharmacology and experimental therapeutics, 2011, 337:797-804.
[2]. jun matsukawa, yasunobu hori, haruyuki nishida, et al. a comparative study on the modes of action of tak-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. biochemical pharmacology, 2011, 81:1145-1151.

Properties of Vonoprazan fumarate

storage temp.  Store at -20°C
solubility  insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
form  solid

Safety information for Vonoprazan fumarate

Computed Descriptors for Vonoprazan fumarate

InChIKey ROGSHYHKHPCCJW-WLHGVMLRSA-N
SMILES N1(S(C2=CC=CN=C2)(=O)=O)C(C2=CC=CC=C2F)=CC(CNC)=C1.C(O)(=O)/C=C/C(O)=O

Abamectin manufacturer

SHOBHA LIFE SCIENCES PRIVATE LIMITED

1Y
Phone:+919121212469
Whatsapp: +91 9121212469
product: Vonoprazon Fumarate 99%
Inquiry

Metrochem API Private Limited

1Y
Phone:+91-4069069999
product: Vonoprazan Fumarate 98%
Inquiry

Centaur Pharmaceuticals Pvt Ltd

1Y
Phone:+912266499100
Whatsapp: +91 2266499100
product: 1260141-27-2 / 881681-01-2 Vonoprazan Fumarate 99%
Inquiry

Anlon Healthcare Pvt Ltd

1Y
Phone:+91-7069690081
Whatsapp: +91-7069690081
product: 1260141-27-2 / 881681-01-2 99%
Inquiry

Mehta API Pvt. Ltd.

1Y
Phone:+91-9920552082
Whatsapp: +91 9920552082
product: Vonoprazan Fumarate 98%
Inquiry

Morepen Laboratories Ltd

1Y
Phone:+91-9818305894
Whatsapp: +91 9818305894
product: Vonoprazan Fumarate 1260141-27-2 / 881681-01-2 99%
Inquiry

Ami Lifesciences Pvt Ltd

1Y
Phone:+91-9426998100
Whatsapp: +91-9426998100
product: 1260141-27-2 / 881681-01-2 Vonoprazan Fumarate 99%
Inquiry

Maithri Drugs Pvt Ltd

1Y
Phone:+91-9848881740
Whatsapp: +91- 9848881740
product: Vonoprazan Fumarate 1260141-27-2 / 881681-01-2 98%
Inquiry

Archerchem Healthcare Pvt., Ltd. (part of Archerchem Group)

Maharashtra
product: Vonoprazan Fumarate
Inquiry

Related products of tetrahydrofuran

You may like

  • 1260141-27-2 Vonoprazan Fumarate 98%
    1260141-27-2 Vonoprazan Fumarate 98%
    1260141-27-2
    View Details
  • 1260141-27-2 98%
    1260141-27-2 98%
    1260141-27-2
    View Details
  • Vonoprazan Fumarate 1260141-27-2 / 881681-01-2 99%
    Vonoprazan Fumarate 1260141-27-2 / 881681-01-2 99%
    1260141-27-2 / 881681-01-2
    View Details
  • Vonoprazan Fumarate 98%
    Vonoprazan Fumarate 98%
    View Details
  • Vonoprazan Fumarate 98%
    Vonoprazan Fumarate 98%
    1260141-27-2 / 881681-01-2
    View Details
  • Vonoprazon Fumarate 99%
    Vonoprazon Fumarate 99%
    1260141-27-2
    View Details
  • TAK-438 98% (HPLC) CAS 1260141-27-2
    TAK-438 98% (HPLC) CAS 1260141-27-2
    1260141-27-2
    View Details
  • 1260141-27-2 / 881681-01-2 Vonoprazan Fumarate 99%
    1260141-27-2 / 881681-01-2 Vonoprazan Fumarate 99%
    1260141-27-2 / 881681-01-2
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.